rs4788102 — SH2B1 SH2B1/APOBR locus variant

SH2B1 — The Hypothalamic Gatekeeper of Leptin and Insulin Signals

Your hunger, fullness, and metabolic rate are governed by a constant dialogue between hormones in the bloodstream and neurons in the hypothalamus. At the center of this dialogue sits SH2B1, an adaptor protein that amplifies the signals from two of the most critical metabolic hormones: leptin (the long-term satiety signal from fat cells) and insulin (the short-term glucose regulator from the pancreas). rs4788102 is an intronic variant in SH2B1 on chromosome 16p11.2 — part of a genomic region robustly linked to body mass index in multiple large genome-wide association studies¹¹ genome-wide association studies
Studies that simultaneously examine hundreds of thousands of genetic variants across the genome to identify which ones correlate with a trait like BMI across tens of thousands of people. The A allele at rs4788102 tags the risk-increasing haplotype at this locus.

The Mechanism

SH2B1 is an adaptor protein with SH2 and PH domains that integrates multiple upstream hormonal signals. In hypothalamic neurons, it binds to and activates JAK2²² JAK2
Janus kinase 2 — the kinase that is activated when leptin binds its receptor and initiates downstream signaling inside the neuron, the kinase immediately downstream of the leptin receptor. When SH2B1 binds phospho-Tyr813 of JAK2, it stimulates JAK2 kinase activity and recruits insulin receptor substrate 1 (IRS1), feeding the signal into the PI3-kinase pathway that ultimately suppresses appetite and elevates energy expenditure. Without SH2B1, even a normal leptin signal is poorly amplified — the neuron becomes functionally leptin-resistant even with intact receptor expression and normal circulating leptin levels.

A 2020 study³³ 2020 study
Jiang et al. Leptin receptor-expressing neuron Sh2b1 supports sympathetic nervous system and protects against obesity and metabolic disease. Nat Commun, 2020 identified an important circuit: SH2B1 in leptin-receptor-positive neurons activates the sympathetic nervous system and brown adipose tissue⁴⁴ brown adipose tissue
Specialized fat tissue that burns calories as heat rather than storing them — the thermogenic furnace that helps maintain body weight thermogenesis. Mice with SH2B1 deleted from leptin receptor neurons progressively develop obesity, insulin resistance, and fatty liver. The pathway extends further: a 2024 circuit-level study⁵⁵ 2024 circuit-level study
Li et al. SH2B1 Defends Against Energy Imbalance, Obesity, and Metabolic Disease via a Paraventricular Hypothalamus→Dorsal Raphe Nucleus Neurocircuit. Adv Sci, 2024 showed that SH2B1 in paraventricular hypothalamus (PVH) neurons projects to the dorsal raphe nucleus to suppress food intake, with optogenetic activation of this circuit reducing eating and SH2B1 deletion in PVH neurons causing obesity and metabolic disease in both sexes.

SH2B1 also potentiates insulin receptor signaling in peripheral tissues, enhancing IRS1 phosphorylation and protecting it from dephosphorylation — a role that extends its metabolic influence beyond the hypothalamus into muscle, liver, and pancreatic beta cells. The comprehensive mechanistic review⁶⁶ comprehensive mechanistic review
Rui L. SH2B1 regulation of energy balance, body weight, and glucose metabolism. World J Diabetes, 2014 describes how SH2B1 deletion in mice produces the full metabolic syndrome: leptin resistance, insulin resistance, hyperphagia, obesity, and type 2 diabetes.

rs4788102 itself is intronic and does not alter the SH2B1 protein. Its BMI association is attributed to linkage disequilibrium with the nearby functional missense variant rs7498665 (Ala484Thr), which lies in a conserved protein domain of SH2B1 and has been independently associated with serum leptin, body fat, and waist circumference.

The Evidence

The first genetic signal at the SH2B1 locus came from the landmark GIANT consortium GWAS, Willer et al. 2009⁷⁷ Willer et al. 2009
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nature Genetics, 2009. Meta-analysis: Stage 1 n=32,000+; Stage 2 n=59,000+; total >91,000, which identified SH2B1 as one of six newly significant BMI loci (P < 5×10⁻⁸) and noted that it "maps near key hypothalamic regulators of energy balance" alongside MC4R, POMC, and BDNF. The association was confirmed in Speliotes et al. 2010⁸⁸ Speliotes et al. 2010
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature Genetics, 2010 in nearly 250,000 individuals.

Beyond BMI, Prudente et al. 2011⁹⁹ Prudente et al. 2011
The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells. Atherosclerosis, 2011 found the A allele of rs4788102 associated with myocardial infarction in type 2 diabetic patients across three cohorts (OR 1.21, 95% CI 1.04–1.41, p=0.016), with the protective GG genotype preserving insulin-stimulated nitric oxide synthase activity in endothelial cells — a mechanism linking SH2B1 to vascular function. An association with HbA1c in non-diabetic young adults¹⁰¹⁰ HbA1c in non-diabetic young adults
Lange et al. Evidence for Association between SH2B1 Gene Variants and Glycated Hemoglobin. Ann Hum Genet, 2016; n=5,641 European Americans was also identified (P = 2.2×10⁻⁴), suggesting the locus modestly influences glucose metabolism even before diabetes develops. A 2017 GWAS interaction analysis found rs4788102-A associated with BMI in physically active individuals (beta = 0.031 kg/m², P = 1×10⁻⁹), confirming that physical activity does not nullify the genetic signal at this locus.

Not all studies show effects: the SH2B1 locus showed no association with abnormal glucose homeostasis in a European meta-analysis of ~93,000 individuals Prudente et al. 2013¹¹¹¹ Prudente et al. 2013
Nutr Metab Cardiovasc Dis, 2013, and no independent association with central obesity in Chinese children after correction for multiple testing. The BMI signal is most robust in Europeans and in large pooled analyses.

Practical Actions

The SH2B1 pathway governs two parallel defenses against weight gain: satiety amplification (hypothalamus → eat less) and thermogenesis activation (sympathetic nervous system → burn more). Risk allele carriers face reduced efficiency in both. This makes both sides of the energy equation relevant: strategies that enhance peripheral satiety hormone responses and strategies that support sympathetically-mediated thermogenesis are particularly targeted for this genotype.

The modest but established vascular signal at this locus — through impaired endothelial NOS activity — makes metabolic monitoring more important for A allele carriers, especially those with additional cardiometabolic risk factors.

Interactions

rs4788102 is in linkage disequilibrium with rs7498665 (Ala484Thr), the functional missense variant in SH2B1 that directly alters protein structure. The two SNPs are co-associated across multiple studies and likely tag the same functional haplotype.

SH2B1 sits biologically upstream of the leptin receptor effector pathway shared with LEPR rs1137101 (Gln223Arg). When the leptin receptor itself is impaired (rs1137101 risk genotype), the upstream signal is already reduced before it reaches SH2B1. When SH2B1 is reduced in effectiveness (rs4788102 A allele), even a normal receptor signal is poorly amplified. Carriers of risk alleles at both loci face compound impairment at two nodes in the same hypothalamic satiety cascade.

Within the broader GIANT consortium obesity loci — FTO (rs9939609), MC4R (rs17782313), GNPDA2 (rs10938397) — each operates through a distinct mechanism. SH2B1's contribution is specifically through leptin signaling amplification and brown fat thermogenesis, complementing FTO's adipocyte thermogenesis mechanism and MC4R's downstream appetite suppression role. GWAS evidence shows these loci have additive, not multiplicative, BMI effects.